Bullish vs. Bearish (2 opinions)
Social Sentiment 0.43

CANF Forecast and Technical Stock Analysis

Buy candidate since 2019-07-12 Gain 6.63%

Can-Fite BioPharma Ltd fell by -2.09% in the last day ( Friday, 19th Jul 2019 ) from $3.30 to $3.23 During the day the stock fluctuated 4.44% from a day low at $3.15 to a day high of $3.29. The price has risen in 7 of the last 10 days and is up by 10.27% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -143 769 shares and in total 41 146 shares bought and sold for approximately $132 943.00.

Quick summary:

  • 30 day high of the CANF stock price was $3.40 and low was $2.76.
  • 90 day high was $8.88 and low was $0.38.
  • 52 week high for Can-Fite BioPharma Ltd - $8.88 and low - $0.38.
Top Trending Stocks


Can-Fite BioPharma Ltd lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 29.58% during the next 3 months and, with 90% probability hold a price between $2.39 and $10.21 at the end of this period.

Top Golden Star Stocks


Can-Fite BioPharma Ltd holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $3.11 and $2.97. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday July 18, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

A buy signal from a double bottom formation was found on Thursday July 11, 2019 with a target of $3.10. Despite the objective of the signal formation has been reached the stock may continue to perform well.

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 66 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

Can-Fite BioPharma Ltd finds support from accumulated volume at $3.22.

Support: $3.22 Price: $3.23 Resistance: $3.26


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.14 between high and low, or 4.44%. For the last week the stock has had a daily average volatility of 5.82%.

Our recommended stop-loss: $3.07 (-4.96%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 day(s) ago.)

5.82 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Buy Candidate Downgraded


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Strong Buy Candidate to a Buy Candidate.

Will CANF stock price go up or down on Tue, 23 Jul 2019?

Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 StockInvest.us donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at